ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424 | -4.5% | 20,348 | +9.8% | 0.05% | -43.2% |
| Q2 2023 | $444 | +37.5% | 18,535 | +8.1% | 0.08% | +84.1% |
| Q1 2023 | $323 | -25.7% | 17,142 | -37.2% | 0.04% | -33.3% |
| Q4 2022 | $435 | -99.9% | 27,316 | +48.4% | 0.07% | +43.5% |
| Q3 2022 | $301,000 | -14.0% | 18,401 | -25.9% | 0.05% | -25.8% |
| Q2 2022 | $350,000 | -15.3% | 24,834 | +45.5% | 0.06% | -8.8% |
| Q1 2022 | $413,000 | -15.9% | 17,072 | -18.9% | 0.07% | -19.0% |
| Q4 2021 | $491,000 | +3.6% | 21,048 | -26.3% | 0.08% | +47.4% |
| Q3 2021 | $474,000 | -17.0% | 28,553 | +21.9% | 0.06% | -13.6% |
| Q2 2021 | $571,000 | -16.4% | 23,417 | -11.5% | 0.07% | -45.5% |
| Q1 2021 | $683,000 | -49.9% | 26,456 | +3.9% | 0.12% | -26.7% |
| Q4 2020 | $1,362,000 | – | 25,468 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |